Neuromodulation and antenatal depression: a review

Neuromodulation and antenatal depression: a review

BACKGROUND Depression during pregnancy affects 5%-8% of women. While the percentage of women in the US taking serotonin reuptake inhibitors during pregnancy has risen over the last decade, pregnant women continue to report that they prefer non-pharmacologic interventions. OBJECTIVE We review the literature regarding neuromodulation techniques for major depressive disorder during pregnancy. Th...

Neuromodulation for treatment-resistant depression

Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy, vagus nerve stimulation, direct cortical s...

Neuromodulation durch Vagusnervstimulation bei Depression

Neuromodulation therapies and treatment-resistant depression

BACKGROUND Patients with treatment-resistant depression (TRD) who showed partial response to pharmacological and psychotherapeutic interventions need a trial of neuromodulation therapies (NTs). OBJECTIVE This paper aims to review evidence-based data on the use of NTs in TRD. METHOD Using keywords and combined-word strategy, multiple computer searches of PubMed, Google Scholar, Quertle(R), a...

CORRIGENDUM TO: Neuromodulation for treatment-resistant depression

permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes.